Questions and Answers
What veins primarily contribute to the formation of the portal vein?
Which anatomical structure does the portal vein NOT supply directly?
The portal vein enters the liver at which location?
What is the primary classification of causes for portal hypertension?
Signup and view all the answers
Which of the following best describes portosystemic collateral development?
Signup and view all the answers
The main purpose of discussing the anatomy and physiology of the portal venous system is to understand its role in which of the following?
Signup and view all the answers
Which of the following is a common clinical manifestation of portal hypertension?
Signup and view all the answers
What is the significance of understanding different therapeutic options for portal hypertension?
Signup and view all the answers
Which of the following statements about the anatomy of the portal venous system is correct?
Signup and view all the answers
What is the main source of the blood supply to the liver?
Signup and view all the answers
Which measurement represents the difference between the WHVP and FHVP?
Signup and view all the answers
What condition is indicated by a portal venous pressure greater than 15 mmHg?
Signup and view all the answers
At what HVPG value is clinically significant portal hypertension (CSPH) diagnosed?
Signup and view all the answers
What is one of the potential clinical manifestations of clinically significant portal hypertension?
Signup and view all the answers
Which blood vessel is responsible for draining mixed blood from the liver into the inferior vena cava?
Signup and view all the answers
What is the normal range of portal venous pressure considered?
Signup and view all the answers
Which of the following does NOT correlate with the presence of portal hypertension?
Signup and view all the answers
What is the significance of measuring the portal pressure gradient (PPG)?
Signup and view all the answers
What happens when portal pressure gradient (PPG) exceeds 5 mmHg?
Signup and view all the answers
What is the primary action of terlipressin in the treatment of portal hypertension?
Signup and view all the answers
Which of the following best describes the duration of action of octreotide compared to somatostatin?
Signup and view all the answers
Which of the following is a major contraindication for the use of terlipressin?
Signup and view all the answers
What is one potential adverse effect of terlipressin therapy?
Signup and view all the answers
How do non-selective beta-blockers (NSBBs) differ from terlipressin and octreotide in treatment for portal hypertension?
Signup and view all the answers
In treating portal hypertension, the reduction in the hepatic venous pressure gradient (HVPG) is useful for preventing which of the following?
Signup and view all the answers
What is the primary mechanism by which non-selective beta-blockers decrease portal pressure?
Signup and view all the answers
Which statement about carvedilol is accurate?
Signup and view all the answers
Which of the following is a contraindication for the use of non-selective beta-blockers?
Signup and view all the answers
What is a major concern when using vasodilators in patients with cirrhosis?
Signup and view all the answers
What is the primary role of endoscopic variceal band ligation (EBL)?
Signup and view all the answers
How do traditional non-selective beta-blockers affect splanchnic blood flow?
Signup and view all the answers
What is the primary reason EBL is considered superior to EIS?
Signup and view all the answers
Which complication is associated with endoscopic variceal band ligation?
Signup and view all the answers
What is the mechanism by which EBL induces necrosis of varices?
Signup and view all the answers
Which of the following best describes a non-shunt surgical operation for portal hypertension?
Signup and view all the answers
Which procedure is recommended as a rescue therapy for acute variceal bleeding after standard treatments fail?
Signup and view all the answers
What distinguishes partial and selective portosystemic shunts from total shunts?
Signup and view all the answers
Which condition is NOT a complication of endoscopic injection sclerotherapy (EIS)?
Signup and view all the answers
What is the main limitation of non-shunt surgical procedures like the Sujura procedure?
Signup and view all the answers
Study Notes
Portal Hypertension Overview
- Portal hypertension (PH) involves increased pressure within the portal venous system.
- Clinically significant portal hypertension (CSPH) is defined by hepatic venous pressure gradient (HVPG) ≥10 mmHg.
Anatomy and Physiology of the Portal Venous System
- The portal vein is formed by the convergence of the splenic vein and the superior mesenteric vein.
- It drains blood from the gastrointestinal tract, spleen, gallbladder, and pancreas.
- The portal vein enters the liver at the porta hepatis and splits into left and right branches, supplying each liver lobe.
Blood Flow Dynamics
- Total hepatic blood flow is approximately 1600 ml/min; two-thirds is from the portal vein.
- Normal portal vein pressure is between 5 and 10 mmHg.
- Hepatic venous pressure gradient (HVPG) and portal pressure gradient (PPG) are key indicators of portal hypertension.
Measurement of Portal Pressure
- HVPG is calculated by the difference between wedged hepatic venous pressure (WHVP) and free hepatic vein pressure (FHVP).
- Normal HVPG and PPG values are both ≤5 mmHg.
- A portal venous pressure exceeding 15 mmHg or HVPG >5 mmHg indicates PH.
Clinical Manifestations
- Symptoms of CSPH include:
- Esophageal varices and variceal bleeding
- Portal hypertensive gastropathy (PHG)
- Development of portosystemic collaterals
- Ascites
- Hepatorenal syndrome
- Hyponatremia
- Hepatic encephalopathy (HE)
- Cardiopulmonary complications
- CSPH indicates higher risk of liver decompensation.
Therapeutic Management
- Treatment options are aimed at managing bleeding due to portal hypertension. These may include medications, procedures, or surgery tailored to specific complications associated with PH.
Treatment of Portal Hypertension (PH)
- Focus on reducing portal pressure and managing complications like variceal bleeding, ascites, and hepatic encephalopathy (HE).
- Key strategies include pharmacological therapy, endoscopic treatments, and surgical interventions.
Pharmacological Therapy
-
Vasoconstrictors: First-line treatment targeting increased splanchnic blood flow.
- Terlipressin: A synthetic vasopressin analog, effective for acute situations. Contraindicated in severe hypertension or coronary heart disease.
- Octreotide: Somatostatin analog, reduces splanchnic blood flow without significant systemic side effects.
- Non-selective beta-blockers (NSBBs): Propranolol and nadolol reduce cardiac output, and splanchnic blood flow, used for long-term prevention of variceal bleeding.
-
Carvedilol: A potent NSBB with dual action on beta and alpha receptors, effective in reducing hepatic venous pressure gradient (HVPG) and preventing complications.
-
Vasodilators: Such as isosorbide mononitrate, nitroglycerin, and prazocin, decrease intrahepatic resistance but can cause systemic hypotension, thus not recommended for cirrhotic patients.
-
Additional Agents: Include direct-acting antivirals, statins, angiotensin-2 antagonists, and sorafenib which may help decrease portal pressure and resistance.
Endoscopic Therapy
-
Endoscopic Variceal Band Ligation (EBL): Preferred method for treating esophageal varices. Involves placing bands around varices to impede blood flow, causing necrosis.
- Complications: Esophageal ulcerations, retrosternal pain, dysphagia.
-
Endoscopic Injection Sclerotherapy (EIS): Less common, involves injecting sclerosants to induce thrombosis. Risks include esophageal perforation and portal vein thrombosis.
Surgical Treatment
-
Decompressive Shunts:
- Total (e.g., portocaval shunts) vs. Partial/Selective: selective maintains some liver blood flow with lower encephalopathy risk.
- Rebleeding rates after shunt procedures are less than 10%.
-
Non-Shunt Operations:
- Examples include splenectomy combined with gastric and esophageal devascularization (Hassab’s operation).
- Higher risk of rebleeding compared to shunt procedures.
-
Mesenterico-Left Portal Venous Bypass (Rex Shunt): For patients with extrahepatic portal vein thrombosis; creates an anastomosis between the superior mesenteric vein and the left portal vein.
-
Transjugular Intrahepatic Portosystemic Shunt (TIPS):
- A radiological intervention for creating a shunt between the portal vein and hepatic vein, indicated for refractory ascites or bleeding.
- Contraindicated in severe liver failure and significant infections.
-
Liver Transplantation: Reserved for patients with end-stage liver disease, preferred over surgical shunts in these candidates.
Additional Considerations
- Monitor for conditions like hyponatremia in patients on terlipressin and adjust doses of NSBBs based on heart rate and blood pressure.
- Compared to EIS, EBL is more effective and safer for managing variceal bleeding.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz provides an overview of portal hypertension, including its definition and the anatomy of the portal venous system. Participants will also learn about blood flow dynamics and the measurement of portal pressure. Understand the significance of hepatic venous pressure gradient in diagnosing portal hypertension.
